A new instrument for predicting survival of patients with cerebral metastases from breast cancer developed in a homogeneously treated cohort
Authors
Stefan Janssen
Department of Radiation Oncology, University Hospital Lubeck, Lubeck, Germany
Medical Practice for Radiotherapy and Radiation Oncology, Hannover, Germany
Heinke C Hansen
Department of Radiation Oncology, University Hospital Lubeck, Lubeck, Germany
Liesa Dziggel
Department of Radiation Oncology, University Hospital Lubeck, Lubeck, Germany
Steven E Schild
Department of Radiation Oncology, Mayo Clinic Scottsdale, Arizona, U.S.A.
Dirk Rades
Department of Radiation Oncology, University Hospital Lubeck, Lubeck, Germany
Language: English
Page range: 219 - 224
Submitted on: Feb 12, 2019
Accepted on: Mar 27, 2019
Published on: May 8, 2019
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2019 Stefan Janssen, Heinke C Hansen, Liesa Dziggel, Steven E Schild, Dirk Rades, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.